Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

During my visit to CES 2025, I sought out a pair of special smart glasses that could give me hope for my son's future.

A synthetic molecule created in Italy has proven capable to reawakening retinal neurons to stave off degenerative illnesses ...

Maintaining good eyesight is more critical than ever in today's fast-paced world. With rising screen time and environmental ...

WVU celebrated the kickoff of construction on the new WVU Eye Institute Friday morning. The cold weather moved what had been planned as an outside groundbreaking indoors — to a room in the Erickson ...

It is believed to be the first time that Lytenava (bevacizumab gamma) has been cleared for reimbursement in any European country, coming after ... of the retina (the macula), causing blurred ...

ST highlights six innovative products aiming to help people to age more gracefully. Read more at straitstimes.com.

On this week's episode, we catch up with the Digital Trends team from CES 2025 as they share their favorite tech from CES ...

High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

People have to start recognizing that there are some good numbers coming ... medicines for eye diseases, dermatitis, asthma, ...